[-] Show simple item record

dc.contributor.advisorAhsan, Humeraeng
dc.contributor.authorBahador, Farshad Michaeleng
dc.contributor.authorKim, Thomaseng
dc.date.issued2010-11eng
dc.description.abstractReversible Posterior Encephalopathy Syndrome (PRES) is characterized by confusion, drowsiness, vomiting, seizure and visual loss. This neurologic syndrome was first described in 1996. Almost half of those patients had undergone bone marrow or solid organ transplant, and were under treatment with Cyclosporin or Tacrolimus. During the past decade its association with other co-morbidities including hypertensive encephalopathy, pre-eclamspisa/eclampsia, autoimmune diseases, post-streptococcal glomerulonephritis and Henoch-Schonlein has been shown.eng
dc.identifier.urihttp://hdl.handle.net/10355/9161eng
dc.relation.ispartof2010 Health Sciences Research Day (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. Health Sciences Research Day.eng
dc.subjectaltered mental statuseng
dc.subjectbrain edemaeng
dc.subject.lcshSepticemiaeng
dc.subject.lcshCerebral edemaeng
dc.subject.lcshDeliriumeng
dc.titleAtypical presentation of posterior reversible encephalopathy syndrome in a patient with sepsiseng
dc.typeOthereng


Files in this item

[PDF]
[PDF]

This item appears in the following Collection(s)

[-] Show simple item record